Participation in the Congress is open to clinicians and researchers throughout the world interested in the exchange of information on drug therapy in HIV infection. Only fully paid, pre-registered delegates will be allowed to take part in the congress.

International experts share their knowledge with a practical approach. In six sessions, offered weekly, this course is a tool that facilitates the basic concepts for better diagnosis and treatment.